HITIQ (ASX:HIQ) has announced its receipt of an approval from the US patent office protecting its concussion management IP. The company is a unique one on the ASX; it provides software and hardware designed to monitor concussive impacts in the brain incurred by sports players. This is done through scans which are backed by a mouthguard product containing inbuilt sensors. It is this product, Nexus, now the subject of a patent in the US IP system. “Receiving approval for our maiden US patent signals our technology as globally relevant and helps forge a pathway into the US, our key commercial jur…